These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6439961)

  • 1. [Meningococcal meningitis: bacterial virulence, antibodies or complement?].
    Pujadas Capmany R; Jané Pesquer J
    Med Clin (Barc); 1984 Nov; 83(16):671-3. PubMed ID: 6439961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
    García Moreno J; Prat Miranda MS; Vicent P; Calderón B
    Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent results on epidemic meningococcal meningitis.
    Achtman M; Crowe BA; Olyhoek A; Strittmatter W; Morelli G
    J Med Microbiol; 1988 Jul; 26(3):172-7. PubMed ID: 3134549
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococci.
    Sippel JE
    Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of a group B Neisseria meningitidis vaccine.
    Frasch CE
    Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
    [No Abstract]   [Full Text] [Related]  

  • 6. [Occurrence of complement defects in meningococcal disease: who should be examined?].
    Nielsen HE; Magnussen P; Lind I
    Ugeskr Laeger; 1991 Apr; 153(16):1113-6. PubMed ID: 1902602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal vaccines.
    Poolman JT
    J Med Microbiol; 1988 Jul; 26(3):170-2. PubMed ID: 3134548
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complement deficiencies and meningococcal disease in The Netherlands].
    Swart AG; Fijen CA; te Bulte MT; Daha MR; Dankert J; Kuijper EJ
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1147-52. PubMed ID: 8316311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defences against meningococcal infections.
    Lancet; 1985 Oct; 2(8461):929-30. PubMed ID: 2865427
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on serum meningococcal antibodies in patients with meningococcal meningitis and a healthy population].
    Pang HM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Jul; 22(4):233-5. PubMed ID: 3146488
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic diversification of Neisseria meningitidis during waves of colonization and disease in the meningitis belt of sub-Saharan Africa.
    Leimkugel J; Forgor AA; Dangy JP; Pflüger V; Gagneux S; Hodgson A; Pluschke G
    Vaccine; 2007 Sep; 25 Suppl 1():A18-23. PubMed ID: 17531357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meningococcal disease in The Netherlands].
    Spanjaard L; Bol P
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):100-3. PubMed ID: 2493588
    [No Abstract]   [Full Text] [Related]  

  • 15. Disease and mortality caused by Neisseria meningitidis. The role of endotoxin liberation as a virulence factor.
    Andersen BM
    J Oslo City Hosp; 1983; 33(4-5):37-68. PubMed ID: 6410031
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis.
    Brooks GF; Lammel CJ; Blake MS; Kusecek B; Achtman M
    J Infect Dis; 1992 Dec; 166(6):1316-21. PubMed ID: 1431249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of meningococcal disease in light of recent Hajj-associated outbreaks.
    Gold R
    Clin Infect Dis; 2003 Mar; 36(6):684-6. PubMed ID: 12627351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Meningococcal meningitis in Spain (1978-1980). I. Epidemiologic studies, serogroups and sensitivity to antimicrobial agents].
    Sáez Nieto JA; Llacer A; Catalá F; Fenoll A; Casal J
    Rev Sanid Hig Publica (Madr); 1981; 55(7-8):831-69. PubMed ID: 6815776
    [No Abstract]   [Full Text] [Related]  

  • 19. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
    Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
    J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
    Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
    J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.